Latest Breaking News On - ழோ கிஷியாங் - Page 1 : comparemela.com

Researchers develop novel targeted therapy for triple-negative breast cancer Researchers from Hong Kong Baptist University (HKBU), in collaboration with Cornell University, have developed a novel targeted therapy for triple-negative breast cancer (TNBC) that uses a specially-designed nano-carrier to deliver the Chinese medicine compound gambogic acid (GA). The invention enhances the anti-cancer effect of GA and reduces its damage to off-target organs. The invention has the potential to become a more effective therapeutic option for TNBC. The study was supported by the Vincent and Lily Woo Foundation, and the research findings have been published in the international medical journal Frontiers in Oncology.

Zhao xiangTsang shiu timEmily hendersonLily woo foundationProfessor chu chih chang at cornell universityHong kong baptist universityResearch divisionSchool of chinese medicineCornell universityProfessor bian zhaoxiangTsang shiu tim endowed professorChinese medicine clinical studiesClinical divisionChinese medicineAssistant professorProfessor chu chih chang